Companies: 10,795·Total market cap: $144.5T
Gritstone bio, Inc.

Gritstone bio, Inc.

GRTSNASDAQHealthcare
$0.03
$-0.02(-31.78%)
Market Cap$3803110
P/E Ratio—
52W High$3.17
52W Low$0.03
Overview

Gritstone bio, Inc. (GRTS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001656634 · GRTS · NASDAQ · as of Jun 9, 2026

Filing snapshot

426
Total Filings
4
Latest Form
2025-04-08
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001656634 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-03-05
Fiscal Year End
Mar 5, 2024
Accession No.
0000950170-24-025855
Primary Document
grts-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001656634 · Accession 0000950170-24-025855

Latest Key Filings

10-QQuarterly Report
10-Q
2024-08-13
View 10-Q on SEC
8-KCurrent Report
8-K
2025-04-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2025-04-04
View
8-KCurrent Report
8-K
2025-04-04
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
S-8 POSS-8 POS
S-8 POS
2025-03-28
View
Showing 1–15 of 287 filingsForm 4 / 144 hidden· 426 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001656634  |  Exchange: NASDAQ · Healthcare

Gritstone bio, Inc. (NASDAQ: GRTS) has submitted 426 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001656634, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Gritstone bio, Inc.'s most comprehensive regulatory disclosure. The most recent Gritstone bio, Inc. 10-K was filed on 2024-03-05 for fiscal year ending 2024. Historical GRTS 10-K annual reports are available from 2018 through 2024.

Investors researching Gritstone bio, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
QTTB SEC Filings →APTO SEC Filings →GMDA SEC Filings →BCEL SEC Filings →UBX SEC Filings →RVLP SEC Filings →VIVS SEC Filings →AFMD SEC Filings →
→ GRTS Financials→ GRTS Earnings→ GRTS Insider Trades

Frequently Asked Questions

GRTS SEC Filings · 8 questions

Gritstone bio, Inc. (GRTS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 426 filings and access original documents at no cost. Gritstone bio, Inc.'s CIK is 0001656634.

GRTS SEC filingsGritstone bio, Inc. SEC documentsfind GRTS 10-K